← Evidence map

TrialVaccine2014

Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination.

Josianne Nitcheu Tefit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

31 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25218293